PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 17, 2026ACS Nano0 citations

Targeting Hepatic Stellate Cells with Chylomicron-Mimic Nanoemulsion for Liver Fibrosis

Cellular Adaptive Component-Mediated Targeting of Chylomicron-Mimic Nanoemulsion to Hepatic Stellate Cells for Liver Fibrosis

View Full Paper

Authors

YHYilong HuYQY. QiJMJiapeng Mao

Discussion

Loading...

Member takes

Overview

Cell adaptive component-based strategy targets liver fibrosis, highlighting a novel antifibrotic approach.

Key Points

  • To investigate a targeted therapy strategy for liver fibrosis using a chylomicron-mimic nanoemulsion.
  • Developed a chylomicron-like lipid nanoemulsion for liver targeting.
  • Achieved cellular-level targeting via macrophage phagocytosis and HSC uptake.
  • Employed phosphatidylinositol for enhanced endocytic trafficking.
  • Combined nanoemulsion therapy with PPAR-γ agonists.
  • The nanoemulsion suppressed early fibrosis by reducing ERS in HSCs.
  • Combination treatment with PPAR-γ agonists reversed advanced fibrosis.
  • Targeting enabled organ and cellular-level drug delivery.
Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Hu et al. (2026) studied this question.

synapsesocial.com/papers/69b8ef12deb47d591b8c52f8https://doi.org/10.1021/acsnano.6c00741
Ask AI
Helpful
Bookmark
Share
View Full Paper